Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Houston › NPI 1558717827
Lab

Concord Life Sciences, LLC

Concord Life Sciences, LLC was paid $1.26M by Medicaid between Jan 2018 and Dec 2024, across 133 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 30% of everything it billed.

33Billing provider infoCONCORD LIFE SCIENCES, LLC
HOUSTON, TX 77058
33aNPI1558717827assigned 05/05/2016
33bProvider typeClinical Medical Laboratory
28Total paid$1.26M
24GClaims519,216
24DCodes billed133
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#60 of 436
Median peer was paid$17K
This provider vs. median73×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20187,270$11K
20195,117$8K
20203,792$41K
202132,730$259K
202251,442$183K
2023172,874$318K
2024incomplete245,991$443K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 30% 16,344 13,681 $374K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 15% 15,974 13,682 $189K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 9.3% 3,957 3,796 $118K
87481 6.2% 15,703 13,640 $78K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5.8% 6,850 6,496 $73K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.5% 2,036 1,557 $57K
87653 3.1% 15,694 13,670 $39K
87640 3.0% 15,698 13,671 $37K
87500 2.8% 10,828 9,484 $35K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2.8% 14,504 12,572 $35K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.3% 51,728 37,810 $29K
87641 2.0% 10,867 9,429 $25K
121 more codes
80053 Comprehensive metabolic panel 1.9% 30,603 $24K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.4% 8,837 $17K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.2% 1,646 $15K
80048 Basic metabolic panel (calcium, ionized) 1.1% 23,328 $14K
84443 Thyroid stimulating hormone (TSH) <1% 14,039 $11K
80061 Lipid panel <1% 12,348 $11K
83036 Hemoglobin; glycosylated (A1C) <1% 15,268 $10K
80050 General health panel <1% 403 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 805 $6K
80164 <1% 4,367 $5K
82607 <1% 4,929 $5K
83880 <1% 2,068 $5K
80177 <1% 2,172 $3K
84439 <1% 4,966 $3K
82746 <1% 2,097 $2K
83735 <1% 5,336 $2K
82140 <1% 1,922 $2K
84481 <1% 1,552 $2K
82728 <1% 1,967 $2K
86376 <1% 2,071 $2K
83970 <1% 530 $2K
84134 <1% 1,923 $1K
85610 <1% 3,673 $1K
84403 <1% 430 $1K
83550 <1% 1,721 $1K
83540 <1% 2,233 $1K
80185 <1% 835 $980.46
84270 <1% 389 $861.09
82627 <1% 366 $855.51
81003 <1% 4,254 $803.28
80076 <1% 982 $791.37
81001 <1% 5,489 $763.69
80202 <1% 343 $751.77
84153 <1% 487 $751.72
83001 <1% 366 $715.07
82533 <1% 367 $627.18
86140 <1% 746 $577.46
82565 <1% 1,142 $544.99
80069 <1% 1,082 $531.63
82550 <1% 648 $484.29
84100 <1% 1,286 $476.10
80051 <1% 751 $453.88
80156 <1% 249 $423.79
84520 <1% 1,107 $402.64
82947 <1% 1,109 $395.93
80235 <1% 89 $368.17
86141 <1% 200 $350.76
80162 <1% 173 $289.72
85651 <1% 696 $263.27
84550 <1% 722 $253.51
82570 <1% 439 $230.41
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 503 $227.48
82043 <1% 341 $204.07
84132 <1% 484 $190.33
84295 <1% 331 $176.89
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 581 $171.65
87493 <1% 42 $167.14
84144 <1% 97 $159.81
82374 <1% 273 $156.86
85652 <1% 258 $154.60
84146 <1% 99 $148.40
85007 <1% 3,959 $146.52
82435 <1% 266 $134.37
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 49,106 $103.41
80361 <1% 72 $99.36
84156 <1% 191 $82.86
80349 <1% 58 $80.57
81002 <1% 295 $68.78
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 58 $68.23
87086 Culture, bacterial; quantitative colony count, urine <1% 1,413 $66.55
82272 <1% 181 $55.18
84480 <1% 60 $54.77
80354 <1% 55 $53.82
80355 <1% 70 $49.48
80346 <1% 57 $49.32
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) <1% 89,935 $36.83
80353 <1% 54 $33.72
82248 <1% 83 $31.47
80365 <1% 58 $31.36
80348 <1% 55 $31.36
80372 <1% 56 $31.36
82652 <1% 13 $30.72
85014 <1% 107 $25.82
85018 <1% 110 $25.82
87088 <1% 114 $21.24
87186 <1% 917 $21.16
87077 <1% 915 $19.77
85730 <1% 47 $19.38
84436 <1% 50 $17.36
80178 <1% 18 $16.21
80373 <1% 55 $15.68
80369 <1% 49 $15.49
80338 <1% 49 $14.95
80333 <1% 51 $14.95
80360 <1% 52 $13.63
80357 <1% 55 $13.63
80368 <1% 51 $13.63
80371 <1% 54 $13.63
80358 <1% 55 $13.44
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 90 $12.91
80356 <1% 53 $12.01
80359 <1% 51 $11.21
80321 <1% 54 $10.38
80345 <1% 55 $10.03
85049 <1% 29 $9.03
85379 <1% 48 $8.55
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 5,041 $7.81
85027 <1% 39 $5.64
87631 <1% 28 $4.15
82040 <1% 14 $4.09
36415 Collection of venous blood by venipuncture <1% 5,668 $1.50
80366 0% 50 $0.00
80325 0% 50 $0.00
80351 0% 49 $0.00
80323 0% 51 $0.00
80342 0% 51 $0.00
84466 0% 15 $0.00
83992 0% 49 $0.00
80337 0% 49 $0.00
80363 0% 50 $0.00
82951 0% 45 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLIGHT, CHRISTOPHER (CFO)